1. Machado ES, Soares FP, Vianna de Abreu E, Souza TAC, Meves R, Grohs H, et al. Systematic review of platelet-rich plasma for low back pain. Biomedicines. 2023;11(9):2404.
2. Collins T, Alexander D, Barkatali B. Platelet-rich plasma: a narrative review. EFORT Open Rev. 2021;6(4):225-35.
3. Nazaroff J, Oyadomari S, Brown N, Wang D. Reporting in clinical studies on platelet-rich plasma therapy among all medical specialties: a systematic review of Level I and II studies. PLoS One. 2021;16(4):e0250007.
4. Akeda K, Takegami N, Yamada J, Fujiwara T, Ohishi K, Tamaru S, et al. Platelet-rich plasma-releasate for the treatment of discogenic low back pain patients: long-term follow-up survey. Medicina (Kaunas). 2022;58(3):428.
5. Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, Harrison JR, Gribbin CK, LaSalle EE, et al. Lumbar intradiskal platelet-rich plasma injections: a prospective, double-blind, randomized controlled study. PM R. 2016;8(1):1-10.
6. Li P, Zhang R, Zhou Q. Efficacy of platelet-rich plasma in retarding intervertebral disc degeneration: a meta-analysis of animal studies. Biomed Res Int. 2017;2017:7919201.
7. Sanapati J, Manchikanti L, Atluri S, Jordan S, Albers SL, Pappolla MA, et al. Do regenerative medicine therapies provide long-term relief in chronic low back pain: a systematic review and meta-analysis. Pain Physician. 2018;21(6):515-40.
8. Machado ES, Ambach MA, Caldas JM, Wei JJ, Bredemeier M. Personalized multitarget biologic injection in the spine: prospective case series of multitarget platelet-rich plasma for low back pain. Regen Med. 2022;17(1):11-22.
9. Navani A, Ambach M, Calodney A, Rosenthal R, Li G, Mahoney CB, et al. The safety and effectiveness of orthobiologic injections for discogenic chronic low back pain: a multicenter prospective, crossover, randomized controlled trial with 12 months follow-up. Pain Physician. 2024;27(1):E65-77.
10. El-Kadiry AE, Lumbao C, Rafei M, Shammaa R. Autologous BMAC therapy improves spinal degenerative joint disease in lower back pain patients. Front Med (Lausanne). 2021;8:622573.
11. Her YF, Kubrova E, Martinez Alvarez GA, D’Souza RS. The analgesic efficacy of intradiscal injection of bone marrow aspirate concentrate and culture-expanded bone marrow mesenchymal stromal cells in discogenic pain: a systematic review. J Pain Res. 2022;15:3299-318.
12. Rothoerl R, Tomelden J, Alt EU. Safety and efficacy of autologous stem cell treatment for facetogenic chronic back pain. J Pers Med. 2023;13(3):436.
13. Vadalà G, Russo F, Lavazza C, Petrucci G, Ambrosio L, Budelli S, et al. Intradiscal mesenchymal stromal cell therapy for the treatment of low back pain due to moderate-to-advanced multilevel disc degeneration: preliminary report of the DREAM Study. JOR Spine. 2025;8(2):e70086.
14. Beall DP, Bae HW, DePalma MJ, Amirdelfan K, Tavel E, Davis TT, et al. Efficacy and safety of allogeneic mesenchymal precursor cells with and without hyaluronic acid for treatment of chronic low back pain. Spine J. 2025;S1529-9430(25)00164-0.
15. Felipone WK, Mambro L de, Ranieri BR, Ivanov GZ, Meves R, Martins L, et al. The controlled release of platelet-rich plasma-loaded alginate repairs muscle damage with less fibrosis. Am J Sports Med. 2025;53(5):1152-63.